Republic Act 9288 is otherwise known as?

Republic Act 9288 is known as the Newborn Screening Act, which was enacted to establish a program for the early detection of certain genetic and metabolic conditions in newborns. The law mandates that all newborns in the Philippines be screened for specific disorders to ensure timely intervention and management. This is crucial for preventing serious health complications, developmental delays, or even death in affected infants.

The significance of this act lies in its ability to improve neonatal health outcomes through early identification of conditions that are often asymptomatic at birth. By having a standardized newborn screening protocol, healthcare providers can implement necessary treatments or referrals, addressing potential health issues before they become severe.

The other options refer to unrelated legislation: the Dangerous Drugs Act pertains to the regulation of controlled substances; the PRC Modernization Act involves reforms in the Professional Regulation Commission; and the Water Analysis Law addresses water quality and safety standards. Each of these acts serves a different purpose and targets distinct public health concerns, making the Newborn Screening Act the correct association with Republic Act 9288.